nan 190 has been researched along with pentobarbital in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costa, EA; de Brito, AF; De Lima, TC; Fajemiroye, JO; Galdino, PM; Martins, JL; Menegatti, R | 1 |
1 other study(ies) available for nan 190 and pentobarbital
| Article | Year |
|---|---|
Central pharmacological activity of a new piperazine derivative: 4-(1-phenyl-1h-pyrazol-4-ylmethyl)-piperazine-1-carboxylic acid ethyl ester.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Dose-Response Relationship, Drug; Flumazenil; Male; Maze Learning; Mice; Pentobarbital; Piperazines; Pyrazoles; Serotonin; Sleep; Time Factors | 2012 |